e2se.energy

DC1s shield Tpex cells to bolster PD-1 blockade - ScienceDirect

4.8 (494) · € 31.00 · En Stock

Frontiers The PD-1/PD-L1 Pathway Affects the Expansion and

Blockade of PD-1/PD-L1 increases effector T cells and aggravates

EGR1 Monoclonal Antibody (HEGR1DS), PE (12-9851-42)

Pamela S. Ohashi's research works University of Toronto, Toronto

IJMS, Free Full-Text

APExBIO - Vacuolin-1 , lysosomal exocytosis inhibitor , CAS

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1

Identification of Potential Plk1 Targets in a Cell-Cycle Specific

Frontiers The PD-1/PD-L1 Pathway Affects the Expansion and

PD-1 blockade therapy promotes infiltration of tumor-attacking

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T